[go: up one dir, main page]

DE69722630D1 - Therapeutisches mittel zur behandlung von nierenerkrankungen - Google Patents

Therapeutisches mittel zur behandlung von nierenerkrankungen

Info

Publication number
DE69722630D1
DE69722630D1 DE69722630T DE69722630T DE69722630D1 DE 69722630 D1 DE69722630 D1 DE 69722630D1 DE 69722630 T DE69722630 T DE 69722630T DE 69722630 T DE69722630 T DE 69722630T DE 69722630 D1 DE69722630 D1 DE 69722630D1
Authority
DE
Germany
Prior art keywords
lower alkyl
therapeutic agent
different
same
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69722630T
Other languages
English (en)
Other versions
DE69722630T2 (de
Inventor
Shigeki Fujiwara
Yuko Okamura
Haruki Takai
Hiromi Nonaka
Takahiro Moriyama
Kozo Yao
Akira Karasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE69722630D1 publication Critical patent/DE69722630D1/de
Application granted granted Critical
Publication of DE69722630T2 publication Critical patent/DE69722630T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69722630T 1996-02-19 1997-02-19 Therapeutisches mittel zur behandlung von nierenerkrankungen Expired - Fee Related DE69722630T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3041196 1996-02-19
JP3041196 1996-02-19
PCT/JP1997/000439 WO1997029749A1 (fr) 1996-02-19 1997-02-19 Agent therapeutique contre les maladies renales

Publications (2)

Publication Number Publication Date
DE69722630D1 true DE69722630D1 (de) 2003-07-10
DE69722630T2 DE69722630T2 (de) 2004-04-29

Family

ID=12303214

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722630T Expired - Fee Related DE69722630T2 (de) 1996-02-19 1997-02-19 Therapeutisches mittel zur behandlung von nierenerkrankungen

Country Status (6)

Country Link
EP (1) EP0919233B8 (de)
AT (1) ATE241985T1 (de)
AU (1) AU1732697A (de)
CA (1) CA2245896C (de)
DE (1) DE69722630T2 (de)
WO (1) WO1997029749A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
US9771351B2 (en) 2013-07-29 2017-09-26 Kyowa Hakko Kirin Co., Ltd. Wnt signaling inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019342A1 (en) * 1993-02-18 1994-09-01 Kyowa Hakko Kogyo Co., Ltd. Adenosine incorporation inhibitor
JPH09165385A (ja) * 1994-08-26 1997-06-24 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体

Also Published As

Publication number Publication date
EP0919233B8 (de) 2003-08-13
EP0919233A4 (de) 2000-05-10
CA2245896A1 (en) 1997-08-21
WO1997029749A1 (fr) 1997-08-21
EP0919233A1 (de) 1999-06-02
EP0919233B1 (de) 2003-06-04
AU1732697A (en) 1997-09-02
CA2245896C (en) 2003-06-10
DE69722630T2 (de) 2004-04-29
ATE241985T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
HU9600834D0 (en) Quinazoline derivatives
EP1206937A4 (de) Nikroimidazolpräparationen zur äusseren anwendung zur behandlung der dermatose
ATE247654T1 (de) Neue heterozyklische verbindungen
SE9604786D0 (sv) New compounds
NZ337118A (en) 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same useful in treating or preventing arteriosclerotic and/or hyper-lipemia disease, pancreatitis, obesity, hypercholesterolemia and hypertriglyceridemia.
DE69519469D1 (de) Chinazolin-derivate
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
ATE318799T1 (de) Pyrrolderivate und medizinische zubereitung.
EP0640601A4 (de) Benzamid-derivate.
DE69935718D1 (de) Antidiabetische medikamente
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE241985T1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
DE69017855D1 (de) Oxetan-Derivate, ihre Herstellung und ihre Verwendung als Anti-Fungal oder fungizides Mittel.
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE69914563D1 (de) Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
ATE314339T1 (de) Polyhydroxyphenolderivate und mittel zur vorbeugung und therapie von knochen- und knorpelkrankheiten die diese enthalten
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee